| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |